Most recently, Bullock was president and CEO of Atritech Inc which was recently sold to Boston Scientific. Prior to Atritech, he was president and CEO of Endocardial Solutions Inc, which was acquired by St. Jude Medical.
Zyga is focused on the development and marketing of minimally invasive surgical solutions to treat conditions of the spine.
Samsung Biologics honoured at 2026 CDMO Leadership Awards
Frost & Sullivan names Abzena a market-leading ADC CDMO
Vulcan Two signs five-year ERP licence agreement to support ePharmacy expansion
SportsMed Physical Therapy named Physical Therapy Company of the Year
Ensorcell adds new senior leadership team members
GelMEDIX completes USD13m seed financing, announces first partnership
AmacaThera named Life Sciences Ontario Emerging Company of the Year
GenSight Biologics reports first patient treated in GS010 REVISE study
Biophytis secures Asian partnership and investment to advance Phase 3 sarcopenia programme